NEW YORK (GenomeWeb News) – Clinical geneticists in Europe are concerned about the use of direct-to-consumer genetic tests by consumers who have not had in-person discussions with doctors or genetic counselors about these tests, according to a study published in Genome Medicine. The geneticists are particularly worried about when the results are related to serious or actionable health conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.